Sign in

CIK 0000315545

  • Non-accelerated filer
  • Smaller reporting company

PROVECTUS BIOPHARMACEUTICALS, INC.

Sign in to watch
Ticker
PVCT
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
900031917
Phone
+1 866-594-5999
Business address
800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
Former names
PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Exercise or conversion Executive VP Pharmaceuticals acquired 63,281 shares (option exercise)
  4. 4 Exercise or conversion Vice President Pharmaceuticals acquired 100,000 shares (option exercise)
  5. 4 Exercise or conversion Vice President Pharmaceuticals acquired 330,881 shares (option exercise)
  6. 4 Exercise or conversion Chief Executive Officer acquired 6,250 shares (option exercise)
  7. 4 Exercise or conversion Chief Financial Officer acquired 50,000 shares (option exercise)
  8. 4/A Open-market buy 10% owner bought 679,048 shares at $1.05 ($713,000)
  9. 4 Open-market buy 10% owner bought 679,048 shares at $1.05 ($713,000)
  10. 4 Exercise or conversion Chief Executive Officer acquired 9,375 shares (option exercise)
  11. 4 Exercise or conversion Chief Financial Officer acquired 25,000 shares (option exercise)
  12. 4 Exercise or conversion Chief Financial Officer acquired 75,000 shares (option exercise)
  13. 4 Exercise or conversion Chief Executive Officer acquired 9,375 shares (option exercise)
  14. 4 Exercise or conversion Chief Executive Officer acquired 6,250 shares (option exercise)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Exercise or conversion Chief Executive Officer acquired 9,375 shares (option exercise)
  20. 4 Exercise or conversion Vice President Pharmaceuticals acquired 120,920 shares (option exercise)

Page 15 of 19 · 367 filings